Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ERG (v-ets erythroblastosis virus E26 oncogene like (avian))

Identity

Hugo ERG
Location 21q22.2

DNA/RNA

 
  Top : Schematic representation of the ERG gene locus. Exons are depicted as black boxes. Bottom : Structure of alternative transcripts encoded by the ERG gene. Coding exons are shown in grey, 5' UTRs in white and 3' UTRs in black (Adapted from Owczarek et. al., Gene 2004 (324) : 65-77)..
Description 17 exons, 300kb DNA.
Transcription There are five isoforms created by alternative splicing and alternative initiation of translation.

Protein

 
  The different ERG isoforms (Adapted from Duterque-Coquillaud et. al., Oncogene 1993 (8) : 1865-1873)..
Description 5 different isoforms, 38-55 kDa, all contain the ETS DNA binding domain.
Expression ERG-3 is expressed in hematopoietic stem cells and in endothelial cells. In the GNF SymAtlas database, the major ERG expression was found to be in CD34+ cells (that include both hematopoietic stem cells and endothelial cells). ERG was also reported to be expressed in during early T and B cell development, and to be down-regulated in later stages of B and T cell differentiation. Furthemore, ERG was found to be expressed in platelets, megakaryoblastic cell lines and in primary megakaryoblastic leukemia (AMKL or M7-AML) from Down syndrome patients.
Localisation Nuclear
Function Transcription factor
Homology A member of the ETS transcription factors, most homologous to FLI1:.

Mutations

Note No known mutations.

Implicated in

Entity Ewing Sarcoma
Hybrid/Mutated Gene -ERG HYBRID_IMAGE
Abnormal Protein The EWS gene fuses with the carboxy terminal of ERG containing the ets DNA binding domain of ERG.
Oncogenesis In a transgenic mouse model expression of the EWS-ERG in lymphoid progenitors induced T-cell leukemia.
  
Entity Prostate cancer
Hybrid/Mutated Gene Fusion of the the 5' untranslated region of an androgen regulated gene TMPRSS2and all the coding region of the ERG protein.
Abnormal Protein This translocation results in androgen dependent overexpression of ERG.
  
Entity Acute myeloid leukemia (AML) and Ewing Sarcoma
Prognosis Poorer prognosis
Hybrid/Mutated Gene The FUS gene fuses with the carboxy terminal of ERG containing the ets DNA binding domain of ERG.
  
Entity Childhood ALL with either TEL-AML1 (ETV6-RUNX1) translocation or extra copies of chromosome 21 (where ERG is located); AML with complex karyotype and AML with t(X;21)(q25-26;q22) translocation.
Note Overexpression of ERG
Prognosis Overexpression of ERG was reported to predict a worse outcome in acute myeloid leukemia with normal karyotype.
Oncogenesis Overexpression of ERG in the different leukemias and in prostate cancer suggests that overexpression of the full-length ERG may be oncogenic.
  
Entity AMKL: Association of ERG expression with normal and malignant megakaryocytic differentiation.
Oncogenesis ERG was found to be expressed megakaryoblastic leukemic cell lines and in primary leukemic cells from DS patients.
  
Entity ERG involvement in endothelial development.
Note ERG has been reported to regulate genes involved in chondrogenesis and angiogenesis and functions as a modulator of endothelial cell differentiation.
  
Entity ERG involvement in lymphoid development.
Note ERG was reported to be expressed in during early T and B cell development, and to be down-regulated in later stages of B and T cell differentiation.
  

Breakpoints

 

External links

Nomenclature
HugoERG
GDBERG
Entrez_GeneERG  2078  v-ets erythroblastosis virus E26 oncogene homolog (avian)
Cards
AtlasERGID53ch21q22
GeneCardsERG
EnsemblERG [Search_View]   ENSG00000157554 [Gene_View]
GenatlasERG
GeneLynxERG
eGenomeERG
euGene2078
Genomic and cartography
GoldenPathERG  -  21q22.2   chr21:38675671-38792267 -  21q22.3   [Description]    (hg18-Mar_2006)
EnsemblERG - 21q22.3 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneERG
Gene and transcription
GenbankAF015313 [ ENTREZ ]
GenbankAK309469 [ ENTREZ ]
GenbankAM392572 [ ENTREZ ]
GenbankAY204740 [ ENTREZ ]
GenbankAY204741 [ ENTREZ ]
RefSeqNM_004449 [ SRS ]    NM_004449 [ ENTREZ ]
RefSeqNM_182918 [ SRS ]    NM_182918 [ ENTREZ ]
RefSeqAC_000064 [ SRS ]    AC_000064 [ ENTREZ ]
RefSeqAC_000153 [ SRS ]    AC_000153 [ ENTREZ ]
RefSeqNC_000021 [ SRS ]    NC_000021 [ ENTREZ ]
RefSeqNT_011512 [ SRS ]    NT_011512 [ ENTREZ ]
RefSeqNW_001838708 [ SRS ]    NW_001838708 [ ENTREZ ]
RefSeqNW_927384 [ SRS ]    NW_927384 [ ENTREZ ]
AceViewERG AceView - NCBI
UnigeneHs.473819 [ SRS ]    Hs.473819 [ NCBI ]     HS473819 [ spliceNest ]
Fast-db2820 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtP11308 [ SRS]    P11308 [ EXPASY ]     P11308 [ INTERPRO ]
PrositePS00345 ETS_DOMAIN_1 [ SRS ]    PS00345 ETS_DOMAIN_1 [ Expasy ]
PrositePS00346 ETS_DOMAIN_2 [ SRS ]    PS00346 ETS_DOMAIN_2 [ Expasy ]
PrositePS50061 ETS_DOMAIN_3 [ SRS ]    PS50061 ETS_DOMAIN_3 [ Expasy ]
InterproIPR000418 Ets [ SRS ]    IPR000418 Ets [ EBI ]
InterproIPR003118 SAM_PNT [ SRS ]    IPR003118 SAM_PNT [ EBI ]
InterproIPR011991 Wing_hlx_DNA_bd [ SRS ]    IPR011991 Wing_hlx_DNA_bd [ EBI ]
CluSTrP11308
PfamPF00178 Ets [ SRS ]    PF00178 Ets [ Sanger ]    pfam00178 [ NCBI-CDD ]
PfamPF02198 SAM_PNT [ SRS ]    PF02198 SAM_PNT [ Sanger ]    pfam02198 [ NCBI-CDD ]
SmartSM00413 ETS [EMBL]
SmartSM00251 SAM_PNT [EMBL]
BlocksP11308
PDBERG [ SRS ]    ERG [ PdbSum ],   ERG [ IMB ]   ERG [ RSDB ]
HPRD01298
Protein Interaction databases
DIPP11308
IntActP11308
Polymorphism : SNP, mutations, diseases
OMIM165080    [ map ]   
GENECLINICS165080
SNPERG [dbSNP-NCBI]  
SNPNM_004449 [SNP-NCI]  
SNPNM_182918 [SNP-NCI]  
SNPERG [GeneSNPs - Utah]  ERG] [HGBASE - SRS]
HAPMAPERG [HAPMAP]  
COSMICERG [Somatic mutation (COSMIC-CGP-Sanger)]  
TICdbERG [Translocation breakpoints In Cancer]  
HGMDERG
General knowledge
Family BrowserERG [UCSC Family Browser]
SOURCENM_004449
SOURCENM_182918
SMDHs.473819
SAGEHs.473819
GOtranscription factor activity [Amigo]  transcription factor activity
GOsignal transducer activity [Amigo]  signal transducer activity
GOprotein binding [Amigo]  protein binding
GOnucleus [Amigo]  nucleus
GOtranscription [Amigo]  transcription
GOregulation of transcription, DNA-dependent [Amigo]  regulation of transcription, DNA-dependent
GOprotein amino acid phosphorylation [Amigo]  protein amino acid phosphorylation
GOsignal transduction [Amigo]  signal transduction
GOmulticellular organismal development [Amigo]  multicellular organismal development
GOcell proliferation [Amigo]  cell proliferation
GOsequence-specific DNA binding [Amigo]  sequence-specific DNA binding
PubGeneERG
TreeFamERG
CTD2078 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeERG Related clones (RZPD - Berlin)
PubMed
PubMed47 Pubmed reference(s) in LocusLink

Bibliography

New human erg isoforms generated by alternative splicing are transcriptional activators.
Duterque-Coquillaud M, Niel C, Plaza S, Stehelin D
Oncogene. 1993 ; 8 (7) : 1865-1873.
PMID 8510931
 
EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.
Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, Emanuel BS, Evans GA
The Journal of clinical investigation. 1994 ; 94 (2) : 489-496.
PMID 8040301
 
Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
Kong XT, Ida K, Ichikawa H, Shimizu K, Ohki M, Maseki N, Kaneko Y, Sako M, Kobayashi Y, Tojou A, Miura I, Kakuda H, Funabiki T, Horibe K, Hamaguchi H, Akiyama Y, Bessho F, Yanagisawa M, Hayashi Y
Blood. 1997 ; 90 (3) : 1192-1199.
PMID 9242552
 
Selective expression of erg isoforms in human endothelial cells.
Hewett PW, Nishi K, Daft EL, Clifford Murray J
The international journal of biochemistry & cell biology. 2001 ; 33 (4) : 347-355.
PMID 11312105
 
The role of ERG (ets related gene) in cartilage development.
Iwamoto M, Higuchi Y, Enomoto-Iwamoto M, Kurisu K, Koyama E, Yeh H, Rosenbloom J, Pacifici M
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2001 ; 9 Suppl A : S41-S47.
PMID 11680687
 
Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation.
McLaughlin F, Ludbrook VJ, Cox J, von Carlowitz I, Brown S, Randi AM
Blood. 2001 ; 98 (12) : 3332-3339.
PMID 11719371
 
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.
Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR
Cancer cell. 2002 ; 1 (2) : 133-143.
PMID 12086872
 
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.
Baldus CD, Liyanarachchi S, Mrˆ„zek K, Auer H, Tanner SM, Guimond M, Ruppert AS, Mohamed N, Davuluri RV, Caligiuri MA, Bloomfield CD, de la Chapelle A
Proceedings of the National Academy of Sciences of the United States of America. 2004 ; 101 (11) : 3915-3920.
PMID 15007164
 
Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16.
Owczarek CM, Portbury KJ, Hardy MP, O'Leary DA, Kudoh J, Shibuya K, Shimizu N, Kola I, Hertzog PJ
Gene. 2004 ; 324 : 65-77.
PMID 14693372
 
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
Marcucci G, Baldus CD, Ruppert AS, Radmacher MD, Mrˆ„zek K, Whitman SP, Kolitz JE, Edwards CG, Vardiman JW, Powell BL, Baer MR, Moore JO, Perrotti D, Caligiuri MA, Carroll AJ, Larson RA, de la Chapelle A, Bloomfield CD
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 ; 23 (36) : 9234-9242.
PMID 16275934
 
The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L, Toki T, Pimanda JE, Rosenthal E, Machol K, Strehl S, Gˆttgens B, Ito E, Izraeli S
Cancer research. 2005 ; 65 (17) : 7596-7602.
PMID 16140924
 
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM
Science (New York, N.Y.). 2005 ; 310 (5748) : 644-648.
PMID 16254181
 
Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression.
van Zelm MC, van der Burg M, de Ridder D, Barendregt BH, de Haas EF, Reinders MJ, Lankester AC, Rˆ©vˆ©sz T, Staal FJ, van Dongen JJ
Journal of immunology (Baltimore, Md. : 1950). 2005 ; 175 (9) : 5912-5922.
PMID 16237084
 
At the crossroads: diverse roles of early thymocyte transcriptional regulators.
Anderson MK
Immunological reviews. 2006 ; 209 : 191-211.
PMID 16448544
 
ELF4 is fused to ERG in a case of acute myeloid leukemia with a t(X;21)(q25-26;q22).
Moore SD, Offor O, Ferry JA, Amrein PC, Morton CC, Dal Cin P
Leukemia research. 2006 ; 30 (8) : 1037-1042.
PMID 16303180
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written08-2006Liat Rainis-Ganon, Shai Izraeli
Head, Research section, Pediatric Hemato-Oncology, Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel 52621

Citation

This paper should be referenced as such :
Rainis-Ganon L, Izraeli S . ERG (v-ets erythroblastosis virus E26 oncogene like (avian)). Atlas Genet Cytogenet Oncol Haematol. August 2006 .
URL : http://AtlasGeneticsOncology.org/Genes/ERGID53ch21q22.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Jul 14 17:44:11 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.